H.R. 842House119th Congress (2025-2027)In Committee

Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act

To amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.

Introduced January 31, 2025

AI-Generated Summary

Updated November 24, 2025 at 3:09 AM UTC

The Nancy Gardner Sewell Medicare Multi‑Cancer Early Detection Screening Coverage Act would amend the Social Security Act to let Medicare pay for new blood‑based tests that can screen for several cancers at once. It defines which tests qualify, sets how they are covered and paid for, and places limits on how often and for whom they can be used, while protecting existing cancer‑screening benefits.

Key Provisions

  • Adds a new Medicare coverage category for “multi‑cancer early detection screening tests,” defined as FDA‑cleared or approved blood‑based (or comparable) genomic tests that can detect several cancers at once, starting Jan. 1, 2028.
  • Coverage decisions for these tests must follow the standard national coverage determination (NCD) process.
  • Sets the payment rate equal to the current rate for multi‑target stool DNA tests until Jan. 1, 2031, then the lower of that rate or the rate set under section 1834A.
  • Limits one test per beneficiary per year and bars coverage for beneficiaries who have reached a specified age (68 in 2028, increasing by one year each subsequent year).
  • If the U.S. Preventive Services Task Force gives the test an A or B rating, the age and frequency limits do not apply.
  • Amends related sections to reference the new payment provision and to ensure that coverage of these tests does not affect coverage of other cancer screenings, and vice‑versa.

Legislative Activity

Stay on top of the latest movement without scrolling through every action

4 earlier actions
HouseCommittee Latest Action

Reported (Amended) by the Committee on Ways and Means. H. Rept. 119-333, Part I.

October 3, 2025

View full timeline
HouseIntro Referral

Introduced in House

January 31, 2025

HouseIntro Referral

Referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.

January 31, 2025

HouseCommittee

Committee Consideration and Mark-up Session Held

September 17, 2025

HouseCommittee

Ordered to be Reported in the Nature of a Substitute (Amended) by the Yeas and Nays: 43 - 0.

September 17, 2025

HouseCommittee

Reported (Amended) by the Committee on Ways and Means. H. Rept. 119-333, Part I.

October 3, 2025

Floor Debate

2 members

What members said about H.R. 842 on the floor

1 Republican1 Democrat
Terri A. Sewell
Rep. Terri A. SewellD-AL-7 · Nov 20, 2025

Mr. Speaker, I rise in observance of today, November 20, as World Pancreatic Cancer Day. It is a time to shine light on the devastating impact of this disease and dedicate ourselves to improving…

Monica De La Cruz
Rep. Monica De La CruzR-TX-15 · May 6, 2025

Under clause 7 of rule XII, sponsors were added to public bills and resolutions, as follows: H.R. 116: Ms. Boebert. H.R. 151: Ms. Van Duyne. H.R. 255: Mr. Gill of Texas, Mr. Self, and Ms. Crockett.…

Terri A. Sewell
Rep. Terri A. SewellD-AL-7 · Sep 16, 2025

Mr. Speaker, I rise today to welcome to our Nation's Capitol patient advocates from the American Cancer Society Cancer Action Network for their annual fly-in. This week, 700 advocates representing…

Terri A. Sewell
Rep. Terri A. SewellD-AL-7 · Jan 22, 2026

Mr. Speaker, I rise in support of H.R. 842, the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act, which was included in the funding package being considered by the…

Bill Text

Latest available legislative text

Reading Mode
Latest
Introduced in HouseIssued January 31, 2025

I

119th CONGRESS

1st Session

H. R. 842

IN THE HOUSE OF REPRESENTATIVES

January 31, 2025

Mr. Arrington (for himself, Ms. Sewell, Mr. Hudson, Mr. Ruiz, Mrs. Miller-Meeks, and Ms. Kelly of Illinois) introduced the following bill; which was referred to the Committee on Energy and Commerce, and in addition to the Committee on Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned

A BILL

To amend title XVIII of the Social Security Act to provide for Medicare coverage of multi-cancer early detection screening tests.

1.

Short title

This Act may be cited as the Nancy Gardner Sewell Medicare Multi-Cancer Early Detection Screening Coverage Act.

2.

Medicare coverage of multi-cancer early detection screening tests

(a)

Coverage

Section 1861 of the Social Security Act (42 U.S.C. 1395x) is amended—

(1)

in subsection (s)(2)—

(A)

by striking the semicolon at the end of subparagraph (JJ) and inserting ; and; and

(B)

by adding at the end the following new subparagraph:

(KK)

multi-cancer early detection screening tests (as defined in subsection (nnn));

; and

(2)

by adding at the end the following new subsection:

(nnn)

Multi-Cancer early detection screening tests

(1)

In general

The term multi-cancer early detection screening test means a test furnished to an individual for the concurrent detection of multiple cancer types across multiple organ sites on or after January 1, 2028, that—

(A)

is cleared under section 510(k), classified under section 513(f)(2), or approved under section 515 of the Federal Food, Drug, and Cosmetic Act;

(B)

is—

(i)

a genomic sequencing blood or blood product test that includes the analysis of cell-free nucleic acids; or

(ii)

a test based on samples of biological material that provides results comparable to those obtained with a test described in clause (i), as determined by the Secretary; and

(C)

the Secretary determines is—

(i)

reasonable and necessary for the prevention or early detection of an illness or disability; and

(ii)

appropriate for individuals entitled to benefits under part A or enrolled under part B.

(2)

NCD process

In making determinations under paragraph (1)(C) regarding the coverage of a new test, the Secretary shall use the process for making national coverage determinations (as defined in section 1869(f)(1)(B)) under this title.

.

(b)

Payment and standards for multi-Cancer early detection screening tests

(1)

In general

Section 1834 of the Social Security Act (42 U.S.C. 1395m) is amended by adding at the end the following new subsection:

(aa)

Payment and standards for multi-Cancer early detection screening tests

(1)

Payment amount

The payment amount for a multi-cancer early detection screening test (as defined in section 1861(nnn)) is—

(A)

with respect to such a test furnished before January 1, 2031, equal to the payment amount in effect on the date of the enactment of this subsection for a multi-target stool screening DNA test covered pursuant to section 1861(pp)(1)(D); and

(B)

with respect to such a test furnished on or after January 1, 2031, equal to the lesser of—

(i)

the amount described in subparagraph (A); or

(ii)

the payment amount determined for such test under section 1834A.

(2)

Limitations

(A)

In general

No payment may be made under this part for a multi-cancer early detection screening test furnished during a year to an individual if—

(i)

as of January 1 of such year, such individual has attained the age specified in subparagraph (B) for such year; or

(ii)

such a test was furnished to the individual during the previous 11 months.

(B)

Age specified

For purposes of subparagraph (A)(i), the age specified in this subparagraph is—

(i)

for 2028, 68 years of age; and

(ii)

for a succeeding year, the age specified in this subparagraph for the preceding year, increased by 1 year.

(3)

Standards following USPSTF rating

In the case of a multi-cancer early detection screening test that is recommended with a grade of A or B by the United States Preventive Services Task Force, beginning on the date on which coverage for such test is provided pursuant to section 1861(ddd)(1), the preceding provisions of this subsection shall not apply.

.

(2)

Conforming amendments

(A)

Section 1833 of the Social Security Act (42 U.S.C. 1395l) is amended—

(i)

in subsection (a)—

(I)

in paragraph (1)(D)(i)(I), by striking section 1834(d)(1) and inserting subsection (d)(1) or (aa) of section 1834; and

(II)

in paragraph (2)(D)(i)(I), by striking section 1834(d)(1) and inserting subsection (d)(1) or (aa) of section 1834; and

(ii)

in subsection (h), by striking section 1834(d)(1) and inserting subsections (d)(1) and (aa) of section 1834.

(B)

Section 1862(a) of the Social Security Act (42 U.S.C. 1395y(a)) is amended—

(i)

in paragraph (1)—

(I)

in subparagraph (O), by striking and at the end;

(II)

in subparagraph (P), by striking the semicolon at the end and inserting , and; and

(III)

by adding at the end the following new subparagraph:

(Q)

in the case of multi-cancer early detection screening tests (as defined in section 1861(nnn)), which are not reasonable and necessary for the concurrent detection of multiple cancer types across multiple organ sites;

; and

(ii)

in paragraph (7), by striking or (P) and inserting (P), or (Q).

(c)

Rule of construction relating to other cancer screening tests

Nothing in this section, including the amendments made by this section, shall be construed—

(1)

in the case of an individual who undergoes a multi-cancer early detection screening test, to affect coverage under part B of title XVIII of the Social Security Act for other cancer screening tests covered under such title, such as screening tests for breast, cervical, colorectal, lung, or prostate cancer; or

(2)

in the case of an individual who undergoes another cancer screening test, to affect coverage under such part for a multi-cancer early detection screening test or the use of such a test as a diagnostic or confirmatory test for a result of the other cancer screening test.